Abstract
Background and objective Some bulky substituted aromatic aldehydes reacted with urea and ethyl acetoacetate in the presence of acetic acid as a catalyst to yield solely substituted dihydropyridines (Hantzsch-type molecule). In the presence of p-toluene sulfonic acid as a catalyst, the products were only dihydropyrimidines (Biginelli compounds). The same aldehydes yielded dihydropyrimidinones on using acetyl acetone instead of ethyl acetoacetate whatever the catalyst used. These two classes of molecules represent a heterocyclic system of a remarkable antihypertensive effect. The aim of this study was to synthesize certain dihydropyridine and pyrimidinone derivatives with aromatic moiety with bulky substituents to be evaluated for their antihypertensive effect. Methods The aldehydes 3-(substituted-phenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde 3–5, 4-oxo-4H-chromene-3-carbaldehyde (6), and substituted phenylazo-benzaldehyde 7–9 reacted with ethyl acetoacetate and urea in ethanol in the presence of acetic acid to yield dihydropyridines 10–15. Aldehydes 3–9 reacted with ethyl acetoacetate and urea in the presence of p-toluene sulfonic acid to yield dihydropyrimidinones 16–22. Furthermore, the reaction of the aldehydes 3–9 with ethyl acetoacetate and urea in the presence of either acetic acid or p-toluene sulfonic acid yielded the corresponding dihydropyrimidinones 23–29. Results and conclusion The hypotensive activity of compounds 10–14 and 16–20 indicated that the 4-aryl-dihydropyridine derivatives 10–14 showed higher activity than the pyrimidinones 16–20. The most active compound was 4-(1,3-diphenyl-1H-pyrazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid diethyl ester (10) at dose levels of 0.6, 1.2, and 2.4 mg/kg. It showed more or less similar hypotensive activity as the reference drug nifedipene at doses of 1.2 and 2.4 mg/kg. Its LD 50 =298 mg/kg body weight.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.